Roslyn Docktor has two decades of government relations experience delivering policy wins aligned to enterprise objectives in highly regulated and data-driven environments. A trusted advisor to C-suite leaders and policymakers, she helps organizations navigate regulatory complexity, shape durable policy outcomes, and create opportunities for business growth.
As a Principal at Monument and Executive Director of the Health Innovation Alliance, Roslyn advises clients on medical technology policy, FDA AI regulation, data interoperability, and public-private partnerships that accelerate scientific innovation. She builds alignment across industry, government, and patient stakeholders to ensure healthcare innovation translates into real-world impact.
Previously, Roslyn led government and regulatory affairs portfolios at IBM, shaping technology policies adopted across multiple administrations. She advanced responsible AI language integrated into U.S. Executive Orders, secured major legislative wins including provisions in the CHIPS & Science Act and the 21st Century Cures Act, and influenced state and federal regulatory frameworks across AI, health IT, privacy, and cybersecurity.
With experience spanning government and enterprise, Roslyn has created high-impact public-private partnerships including the COVID-19 HPC Consortium and the IBM–VA Cancer Moonshot collaboration. Earlier, she led international technology policy collaborations for the White House. She has served on the Partnership on AI Board of Directors, was a founding member of IBM’s AI Ethics Board, and co-chaired the World Economic Forum Global Futures Council on Agile Governance.
Roslyn is a New York University graduate and former Peace Corps volunteer.